General Information
Revision date
2000-11-30
Product name
Cutivate Ointment
Icons in SDS
Company Information
company name
GlaxoSmithKline
Section 2
Hazardous Ingredients
CHEMICAL NAME: [(6a,11b,16a,17a)-6,9,-difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)androsta- 1,4-diene-17-carbothioic acid, S-fluoromethyl ester] SYNONYMS: Cutivate(R) (fluticasone propionate ointment) Ointment, 0.005% ; Cutivate Ointment ; Cutivate(R) ; fluticasone propionate ointment ; fluticasone 17-propionate ; fluticasone SUBSTANCE CLASS: Corticosteroid, Anti-inflammatory / antipruritic NAME CAS/EINECS/ELINCS % GW LIMITS OTHER LIMITS w/v or w/w (mcg/m3) Fluticasone 80474-14-2 (CAS) 100.0 3 mcg/m3 Not Established propionate 8 hr TWA Not Assigned (ELINCS) Not Assigned (EINICS) SECTION 3: HAZARDS IDENTIFICATION EMERGENCY OVERVIEW: Possible sensitizer. Possible teratogen. HEALTH HAZARDS / EXPOSURE SYMPTOMS: THE RISK OF HEALTH HAZARDS MAY BE REDUCED WHEN Cutivate Ointment IS / ARE HANDLED IN UNIT DOSAGE FORM. May be absorbed through the skin. May cause sensitization by skin contact. Possible risk of harm to the unborn child. See also Section 11: “Toxicological Information”. TO THE BEST OF OUR KNOWLEDGE THE INFORMATION CONTAINED HEREIN IS ACCURATE AS OF THE DATE HEREOF. ANY DETERMINATION AS TO THE SUITABILITY OF THE PRODUCT FOR ANY PARTICULAR PURPOSE, ITS SAFE USE OR DISPOSAL SHALL BE THE RESPONSIBILITY OF THE USER. THE INFORMATION CONTAINED HEREIN IS IN NO WAY INTENDED TO SUPPLEMENT, MODIFY OR SUPERSEDE THE INFORMATION PROVIDED IN THE PRODUCT PACKAGE INSERT WITH RESPECT TO THE USE OF THE PRODUCT FOR MEDICAL PURPOSES. PLEASE REFER TO THE PRODUCT PACKAGE INSERT FOR INFORMATION REGARDING THE USE OF THE PRODUCT FOR MEDICAL PURPOSES. ENVIRONMENTAL EFFECTS: This substance compartmentalizes into the terrestrial environment. PHYSICAL AND CHEMICAL HAZARDS: No hazards currently identified.